No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CDXS240517C2500
- 1.15
- 0.000.00%
15min DelayTrading May 13 12:36 ET
1.20High1.15Low
1.20Open1.15Pre Close22 Volume22 Open Interest2.50Strike Price2.59KTurnover292.70%IV1.93%PremiumMay 17, 2024Expiry Date1.13Intrinsic Value100Multiplier4DDays to Expiry0.02Time Value100Contract SizeAmericanOptions Type0.9075Delta0.1408Gamma3.03Leverage Ratio-0.0216Theta0.0003Rho2.75Eff Leverage0.0007Vega
Intraday
- 5D
- 1D
News
Is Codexis (NASDAQ:CDXS) Using Too Much Debt?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' So it seems the smart money knows that debt - which is usu
Codexis First Quarter 2024 Earnings: Beats Expectations
Express News | Benchmark Reiterates Buy on Codexis, Maintains $9 Price Target
Codexis Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/03/2024 127.27% Benchmark → $9 Reiterates Buy → Buy 02/29/2024 127.27% Benchmark → $9 Upgrades Hold → B
Express News | Codexis Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results
Earnings Call Summary | Codexis(CDXS.US) Q1 2024 Earnings Conference
The following is a summary of the Codexis, Inc. (CDXS) Q1 2024 Earnings Call Transcript:Financial Performance:Codexis reported Q1 2024 total revenues of $17.1 million, an increase of 32% year-over-yea
Comments
loading...
loading...
Despite Codexis' projected growth, its P/S remains below the industry median. Market factors appear to affect the lower-than-expected ratio, indicating potential market hesitation.
follow for daily watchlist 🔥
$Pfizer(PFE.US$ $Abbott Laboratories(ABT.US$ $Capital One Financial(COF.US$ $Codexis(CDXS.US$ $Sigmatron International(SGMA.US$ $Guardforce AI(GFAI.US$ $22nd Century(XXII.US$ $Quoin Pharmaceuticals(QNRX.US$ $Digital World Acquisition Corp(DWAC.US$ $Rivian Automotive(RIVN.US$
$Pfizer(PFE.US$ $Abbott Laboratories(ABT.US$ $Capital One Financial(COF.US$ $Codexis(CDXS.US$ $Sigmatron International(SGMA.US$ $Guardforce AI(GFAI.US$ $22nd Century(XXII.US$ $Quoin Pharmaceuticals(QNRX.US$ $Digital World Acquisition Corp(DWAC.US$ $Rivian Automotive(RIVN.US$
Read more